Amicus Therapeutics Inc (FOLD) — Capital Reinvestment Ratio
Latest as of December 2025:
0.02x
Amicus Therapeutics Inc (FOLD) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow ($16.25 Million) in capital expenditures ($299.00K). See how much free cash does Amicus Therapeutics Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
$16.25 Million
USD
Capital Expenditures
$299.00K
USD
Data as of
Dec 2025
Most recent filing
Amicus Therapeutics Inc Capital Reinvestment Ratio (2007–2025)
This chart tracks Amicus Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Amicus Therapeutics Inc (2007–2025)
Year-by-year Capital Reinvestment Ratio for Amicus Therapeutics Inc from 2007 to 2025. For live market cap and broader valuation context, see market cap of Amicus Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | $33.15 Million | $3.30 Million | ▲ +125.8% |
| 2007 | 0.04x | $15.19 Million | $669.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow